Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg
- 7 January 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Heart Failure Reviews
- Vol. 26 (3), 453-478
- https://doi.org/10.1007/s10741-020-10042-0
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a multifaceted syndrome with a complex aetiology often associated with several comorbidities, such as left ventricle pressure overload, diabetes mellitus, obesity, and kidney disease. Its pathophysiology remains obscure mainly due to the complex phenotype induced by all these associated comorbidities and to the scarcity of animal models that adequately mimic HFpEF. Increased oxidative stress, inflammation, and endothelial dysfunction are currently accepted as key players in HFpEF pathophysiology. However, we have just started to unveil HFpEF complexity and the role of calcium handling, energetic metabolism, and mitochondrial function remain to clarify. Indeed, the enlightenment of such cellular and molecular mechanisms represents an opportunity to develop novel therapeutic approaches and thus to improve HFpEF treatment options. In the last decades, the number of research groups dedicated to studying HFpEF has increased, denoting the importance and the magnitude achieved by this syndrome. In the current technological and web world, the amount of information is overwhelming, driving us not only to compile the most relevant information about the theme but also to explore beyond the tip of the iceberg. Thus, this review aims to encompass the most recent knowledge related to HFpEF or HFpEF-associated comorbidities, focusing mainly on myocardial metabolism, oxidative stress, and energetic pathways.Keywords
This publication has 209 references indexed in Scilit:
- Mitochondrial dynamics in the adult cardiomyocytes: which roles for a highly specialized cell?Frontiers in Physiology, 2013
- Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survivalIUBMB Life, 2012
- Redox-optimized ROS balance: A unifying hypothesisBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricleJournal of Molecular Medicine, 2009
- Dynamic organization of mitochondria in human heart and in myocardial diseaseThe International Journal of Biochemistry & Cell Biology, 2009
- Modulation of Titin-Based Stiffness by Disulfide Bonding in the Cardiac Titin N2-B Unique SequenceBiophysical Journal, 2009
- Na+ transport in cardiac myocytes; Implications for excitation‐contraction couplingIUBMB Life, 2009
- The Cardiac Cycle and the Physiologic Basis of Left Ventricular Contraction, Ejection, Relaxation, and FillingHeart Failure Clinics, 2008
- Mechanism of action of the new anti-ischemia drug ranolazineClinical Research in Cardiology, 2007
- Excitation-contraction coupling and mitochondrial energeticsBasic Research in Cardiology, 2007